V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010513 | 270006176 | 1.7 | 69.7 | Adjuvant (A) | null | 2013-07-17 | ECarboX | N | Y | 270025740 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 270010514 | 270006176 | 1.7 | 90.3 | Disease modification (D) | null | 2017-03-30 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | N | Y | 270025740 | NOT MATCHED |
| 270010515 | 270006176 | null | null | Palliative (P) | 2014-11-29 | 2014-12-02 | Gemcitabine weekly | 2 | N | 270025740 | BEVACIZUMAB |
| 270010516 | 270006177 | 1.71 | 77.4 | Curative (C) | 2014-08-06 | 2014-08-20 | CARBOPLATIN + PACLITAXEL + RT | N | N | 270025781 | CARBOPLATIN |
| 270010517 | 270006178 | 1.82 | 85 | null | null | 2017-04-18 | Cisplatin + Fluorouracil + RT 5day | N | Y | 270025795 | CAPECITABINE + CETUXIMAB + CISPLATIN |
| 270010518 | 270006179 | 1.52 | 63.5 | Curative (C) | 2014-05-14 | 2014-05-15 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 270025803 | CAP + RT |
| 270010519 | 270006179 | 1.7 | 74 | Curative (C) | 2015-08-31 | 2015-10-01 | CVP R | N | N | 270025803 | NOT MATCHED |
| 270010520 | 270006179 | null | 69.3 | Curative (C) | 2014-05-18 | 2014-05-25 | Carboplatin AUC 6 - 10 | N | N | 270025803 | CARBOPLATIN + RT |
| 270010521 | 270006179 | 1.9 | 119 | Curative (C) | 2015-09-17 | 2015-09-22 | CARBOPLATIN + RT | Y | N | 270025803 | CETUXIMAB + RT |
| 270010522 | 270006180 | 1.49 | 55.1 | Adjuvant (A) | null | 2013-04-12 | Bevacizumab + Cape + Oxali 21day | N | Y | 270025837 | CETUXIMAB + IRINOTECAN + MDG |
| 270010523 | 270006181 | 1.75 | 74 | null | 2013-06-19 | 2013-07-03 | CARBOPLATIN + RT | 02 | N | 270025840 | PEMBROLIZUMAB |
| 270010524 | 270013016 | 1.65 | 55.3 | Curative (C) | 2014-10-15 | 2014-11-06 | FOXTROT TRIAL | N | N | 270025842 | CISPLATIN + ETOPOSIDE |
| 270010525 | 270006182 | 0 | 139 | Neo-adjuvant (N) | 2015-11-09 | 2015-11-16 | CETUXIMAB + RT | 2 | N | 270025848 | CETUXIMAB |
| 270010526 | 270006183 | 1.75 | 67.6 | Curative (C) | 2017-10-21 | 2017-11-01 | Cetuximab + Radiotherapy Load | N | N | 270025856 | CETUXIMAB + RT |
| 270010527 | 270006183 | null | 103 | Curative (C) | 2016-11-25 | 2016-11-26 | LOPP | 02 | N | 270025856 | NOT MATCHED |
| 270010528 | 270006183 | null | null | Palliative (P) | 2018-01-14 | 2018-01-17 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270025856 | CETUXIMAB |
| 270010529 | 270017895 | 1.78 | 96 | Curative (C) | 2013-08-28 | 2013-09-04 | Cetuximab + Radiotherapy Load | N | N | 270025862 | CETUXIMAB + RT |
| 270010530 | 270017895 | 1.75 | 93 | Curative (C) | 2014-10-21 | 2014-10-23 | CAP + RT | 02 | N | 270025862 | CAPECITABINE + OXALIPLATIN + RT |
| 270010531 | 270019491 | 1.7 | 95.5 | Adjuvant (A) | 2017-06-12 | 2017-06-24 | Carboplatin AUC 6 - 10 | N | Y | 270025878 | CARBOPLATIN |
| 270010532 | 270019491 | 1.63 | 87 | Curative (C) | 2017-03-03 | 2017-03-12 | Chlorambucil | 99 | N | 270025878 | CHLORAMBUCIL |
| 270010533 | 270006184 | 1.78 | 98 | Adjuvant (A) | 2016-02-26 | 2016-04-14 | Cetuximab 7 day (Cycle 1) | 02 | N | 270000050 | CARBOPLATIN + ETOPOSIDE |
| 270010534 | 270006185 | 0 | 63 | Palliative (P) | 2018-04-07 | 2018-04-13 | Cisplatin + Fluorouracil + RT 5day | 02 | null | 270000230 | CISPLATIN + FLUOROURACIL + RT |
| 270010535 | 270006186 | null | 87 | Adjuvant (A) | 2015-06-20 | 2015-06-20 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 270000276 | CETUXIMAB + RT |
| 270010536 | 270006187 | 1.57 | 68.3 | Palliative (P) | 2015-06-09 | 2015-06-09 | CETUXIMAB + RT | 02 | N | 270000278 | BEVACIZUMAB |
| 270010537 | 270006188 | 1.79 | 79.2 | Curative (C) | 2016-09-25 | 2016-10-02 | Bevacizumab + Irinotecan + MdG | N | N | 270000307 | CAPECITABINE + CISPLATIN |
| 270010538 | 270006189 | 1.63 | 77.5 | Curative (C) | 2013-05-31 | 2013-05-31 | SCOT TRIAL | N | N | 270000361 | RUXOLITINIB |
| 270010539 | 270006190 | 1.64 | 64.6 | Palliative (P) | 2016-08-03 | 2016-08-25 | Bevacizumab 7.5mg/kg | N | N | 270000392 | BEVACIZUMAB |
| 270010540 | 270006191 | 1.58 | 68 | Adjuvant (A) | 2016-09-04 | 2016-09-21 | Cisplatin + Fluorouracil + RT 5day | N | N | 270000403 | CARBOPLATIN |
| 270010541 | 270006192 | 1.75 | 75 | null | 2017-06-08 | 2017-06-24 | Cetuximab + FOLFIRI cycle1 | 2 | N | 270000408 | BENDAMUSTINE + RITUXIMAB |
| 270010542 | 270006193 | null | 72 | Curative (C) | 2014-06-04 | 2014-06-11 | CAPECITABINE + IRINOTECAN | 2 | N | 270000479 | CAPECITABINE + IRINOTECAN |
| 270010543 | 270006194 | 1.78 | 105.25 | Adjuvant (A) | 2016-01-02 | 2016-01-22 | Cetuximab + FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | N | N | 270000482 | CARBOPLATIN |
| 270010544 | 270006194 | 1.75 | 65.8 | Curative (C) | 2018-04-19 | 2018-04-21 | Cetuximab 7 day (Cycle 1) | 2 | N | 270000482 | CARBOPLATIN + PEMETREXED |
| 270010545 | 270016124 | 1.75 | null | Palliative (P) | 2017-12-08 | 2018-01-02 | FLUOROURACIL + MITOMYCIN + RT | N | N | 270000602 | RUXOLITINIB |
| 270010546 | 270006195 | 0 | 60 | null | 2016-01-20 | 2016-02-11 | Carboplatin + Pemetrexed | N | N | 270000882 | BEVACIZUMAB |
| 270010547 | 270006196 | 1.83 | 65.3 | Curative (C) | 2014-07-06 | 2014-08-08 | Enzalutamide | N | Y | 270000922 | CARBOPLATIN + VINORELBINE |
| 270010548 | 270006197 | 1.6 | 41.8 | Curative (C) | 2018-06-28 | 2018-06-30 | CETUXIMAB + OXALIPLATIN + MDG | N | N | 270001072 | GEMCARBO |
| 270010549 | 270006197 | 1.65 | 51.9 | Palliative (P) | 2016-10-30 | 2016-11-08 | Irinotecan 14day | N | N | 270001072 | CETUXIMAB + IRINOTECAN + MDG |
| 270010550 | 270006198 | 1.53 | 67.8 | Palliative (P) | 2017-11-25 | 2017-11-26 | CARBOPLATIN + RT | N | N | 270001328 | CARBOPLATIN + RT |
| 270010551 | 270006199 | 1.5 | 54.9 | Palliative (P) | null | 2018-02-04 | Bortezomib +/- Dexamethasone | null | null | 270001351 | CETUXIMAB + RT |
| 270010552 | 270006200 | 0 | 44.2 | Curative (C) | 2015-10-20 | 2015-10-21 | Carboplatin AUC 6 - 10 | 02 | N | 270001398 | CARBOPLATIN |
| 270010553 | 270006201 | -1 | 111.75 | null | null | 2014-05-31 | Bevacizumab 10mg/kg | null | null | 270001548 | CAPECITABINE + IRINOTECAN |
| 270010554 | 270006202 | 1.65 | null | Curative (C) | null | 2018-02-22 | CHOP | null | null | 270001567 | CVP R |
| 270010555 | 270006203 | 1.8 | 65.8 | Neo-adjuvant (N) | 2014-02-21 | 2014-02-21 | Cetuximab + FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | N | N | 270001569 | SCOT TRIAL |
| 270010556 | 270006204 | 1.77 | 78.1 | Neo-adjuvant (N) | 2016-06-19 | 2016-07-23 | Carboplatin AUC 2 - 5 | N | 2 | 270001634 | CISPLATIN + VINORELBINE |
| 270010557 | 270006205 | 1.78 | 76.7 | Not known (9) | 2016-07-28 | 2016-07-28 | Cisplatin + Etoposide (3 day) | 02 | N | 270001661 | CAPECITABINE + GEMCITABINE |
| 270010558 | 270006206 | 1.22 | 73.9 | Palliative (P) | 2016-09-06 | 2016-09-22 | CVP R | 02 | N | 270001676 | COPP + DACARBAZINE |
| 270010559 | 270006207 | 1.77 | 61.7 | Curative (C) | 2016-12-05 | 2016-12-09 | CETUXIMAB | 01 | N | 270001857 | CARBOPLATIN |
| 270010560 | 270006208 | 1.72 | 68.4 | Adjuvant (A) | 2014-12-29 | 2015-01-16 | CETUXIMAB | N | N | 270001884 | SCOT TRIAL |
| 270010561 | 270006208 | 1.7 | 69.4 | Palliative (P) | 2016-07-13 | 2016-08-03 | Cetuximab + Radiotherapy Load | 02 | N | 270001884 | CARBOPLATIN + RT |
| 270010562 | 270006209 | 1.8 | -1 | Palliative (P) | 2017-06-28 | 2017-07-12 | Cetuximab 7 day (Cycle 1) | null | N | 270002085 | CETUXIMAB |